Form D · Biotechnology
Avinger Inc
Redwood City, CA · CIK 0001506928
Offering snapshot reported Aug 16, 2022 · SEC filing
- Reported sold
- $2.4M Offering amount: $2.4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 8, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 16, 2022 | Initial | $2,400,002 | No comparison | 1 | SEC filing |
| Jul 23, 2018 | Initial | $1,711,284 | No comparison | 4 | SEC filing |
| Sep 15, 2014 | Initial | $34,831,392 | No comparison | 65 | SEC filing |
| Nov 4, 2013 | Initial | $10,465,180 | No comparison | 18 | SEC filing |
| Jul 10, 2012 | Initial | $32,669,822 | No comparison | 38 | SEC filing |
| Sep 29, 2011 | Initial | $21,146,204 | No comparison | 33 | SEC filing |
| Dec 3, 2010 | Initial | $24,233,570 | No comparison | 32 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $350K
- Finders' fees
- $0
- Form D file number
- 021-456093
Includes cash fee paid in a concurrent registered direct offering. The placement agent also received certain expenses and preferred investment options.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Aug 16, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James G Cullen | Director |
| John R. Delfino | Director |
| Tamara N Elias | Director |
| Matthew Ferguson | Executive |
| Donald A. Lucas | Director |
| James B Mc Elwee | Director |
| Jim Muzzy | Director |
| Kenneth Novack | Director |
| Himanshu N Patel | Executive |
| John D. Simpson | Director |
| Jeffrey M Soinski | Director, Executive |
| Nabeel Subainati | Executive |
| Michael Terner | Executive |
| Mark Weinswig | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
400 Chesapeake Drive
Redwood City, CA, 94063
Redwood City, CA, 94063